SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-017299
Filing Date
2017-03-29
Accepted
2017-03-29 16:36:44
Documents
67
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v461464_10k.htm 10-K 768577
2 EXHIBIT 31.1 v461464_ex31-1.htm EX-31.1 11783
3 EXHIBIT 31.2 v461464_ex31-2.htm EX-31.2 11835
4 EXHIBIT 32.1 v461464_ex32-1.htm EX-32.1 6130
5 EXHIBIT 99.1 v461464_ex99-1.htm EX-99.1 55806
12 GRAPHIC pg1img1_ex99-1.jpg GRAPHIC 6666
  Complete submission text file 0001144204-17-017299.txt   5452620

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20161231.xml EX-101.INS 1340802
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20161231.xsd EX-101.SCH 62341
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20161231_cal.xml EX-101.CAL 26516
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20161231_def.xml EX-101.DEF 309663
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20161231_lab.xml EX-101.LAB 340775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20161231_pre.xml EX-101.PRE 347233
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32295 | Film No.: 17722666
SIC: 2836 Biological Products, (No Diagnostic Substances)